Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Merlo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Cell and Developmental Biology|June 8, 2026
Assessment of Vedolizumab and UC-MSC interaction and therapeutic potential in acute graft-versus-host-diseaseAnna Merlo, Serena Zilio, Martina Bernardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2014
Functional avidity-driven activation-induced cell death shapes CTL immunodominanceSilvia Dalla Santa, Anna Merlo, Sara Bobisse, et al.
BMC Cancer|March 19, 2013
Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomasSandra Bernaldo de Quirós, Anna Merlo, Pablo Secades, et al.
Plos One|December 5, 2013
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST)Rita Alaggio, Riccardo Turrini, Daniela Boldrin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2013
Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathwayAnna Merlo, Sandra Bernaldo de Quirós, Inés Sáenz de Santa-María, et al.
British Journal of Cancer|June 17, 2022
Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomideDaniela Catanzaro, Gloria Milani, Angela Bozza, et al.
Oncotarget|December 31, 2016
Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fateAnna Merlo, Cristóbal Bernardo-Castiñeira, Inés Sáenz-de-Santa-María, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2012
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomasDebora Martorelli, Massimo Guidoboni, Valli De Re, et al.
Haematologica|May 9, 2024
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case reportFrancesca Elice, Roberta Sommaggio, Elisa Cappuzzello, et al.
Cytotherapy|May 12, 2025
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trialRoberto Tonelli, Francesca Pischiutta, Francesca Elice, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Cell and Developmental Biology|June 8, 2026
Assessment of Vedolizumab and UC-MSC interaction and therapeutic potential in acute graft-versus-host-diseaseAnna Merlo, Serena Zilio, Martina Bernardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2014
Functional avidity-driven activation-induced cell death shapes CTL immunodominanceSilvia Dalla Santa, Anna Merlo, Sara Bobisse, et al.
BMC Cancer|March 19, 2013
Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomasSandra Bernaldo de Quirós, Anna Merlo, Pablo Secades, et al.
Plos One|December 5, 2013
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST)Rita Alaggio, Riccardo Turrini, Daniela Boldrin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2013
Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathwayAnna Merlo, Sandra Bernaldo de Quirós, Inés Sáenz de Santa-María, et al.
British Journal of Cancer|June 17, 2022
Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomideDaniela Catanzaro, Gloria Milani, Angela Bozza, et al.
Oncotarget|December 31, 2016
Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fateAnna Merlo, Cristóbal Bernardo-Castiñeira, Inés Sáenz-de-Santa-María, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2012
IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomasDebora Martorelli, Massimo Guidoboni, Valli De Re, et al.
Haematologica|May 9, 2024
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case reportFrancesca Elice, Roberta Sommaggio, Elisa Cappuzzello, et al.
Cytotherapy|May 12, 2025
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trialRoberto Tonelli, Francesca Pischiutta, Francesca Elice, et al.
Pageof 5